Literature DB >> 25122040

Effects of tobacco smoke constituents, anabasine and anatabine, on memory and attention in female rats.

Edward D Levin1, Ian Hao2, Dennis A Burke2, Marty Cauley2, Brandon J Hall2, Amir H Rezvani2.   

Abstract

Nicotine has been well characterized to improve memory and attention. Nicotine is the primary, but not only neuroactive compound in tobacco. Other tobacco constituents such as anabasine and anatabine also have agonist actions on nicotinic receptors. The current study investigated the effects of anabasine and anatabine on memory and attention. Adult female Sprague-Dawley rats were trained on a win-shift spatial working and reference memory task in the 16-arm radial maze or a visual signal detection operant task to test attention. Acute dose-effect functions of anabasine and anatabine over two orders of magnitude were evaluated for both tasks. In the radial-arm maze memory test, anabasine but not anatabine significantly reduced the memory impairment caused by the NMDA antagonist dizocilpine (MK-801). In the signal detection attentional task, anatabine but not anabasine significantly attenuated the attentional impairment caused by dizocilpine. These studies show that non-nicotine nicotinic agonists in tobacco, similar to nicotine, can significantly improve memory and attentional function. Both anabasine and anatabine produced cognitive improvement, but their effectiveness differed with regard to memory and attention. Follow-up studies with anabasine and anatabine are called for to determine their efficacy as therapeutics for memory and attentional dysfunction.
© The Author(s) 2014.

Entities:  

Keywords:  Anabasine; anatabine; attention; dizocilpine; memory; radial-arm maze; signal detection task

Mesh:

Substances:

Year:  2014        PMID: 25122040      PMCID: PMC4305443          DOI: 10.1177/0269881114543721

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  43 in total

1.  Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes.

Authors:  P Jacob; L Yu; A T Shulgin; N L Benowitz
Journal:  Am J Public Health       Date:  1999-05       Impact factor: 9.308

Review 2.  Nicotine use in schizophrenia: the self medication hypotheses.

Authors:  Veena Kumari; Peggy Postma
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

3.  Screening of tobacco smoke condensate for nicotinic acetylcholine receptor ligands using cellular membrane affinity chromatography columns and missing peak chromatography.

Authors:  Alexandre Maciuk; Ruin Moaddel; Jun Haginaka; Irving W Wainer
Journal:  J Pharm Biomed Anal       Date:  2007-11-26       Impact factor: 3.935

Review 4.  Alzheimer's disease and age-related memory decline (preclinical).

Authors:  Alvin V Terry; Patrick M Callahan; Brandon Hall; Scott J Webster
Journal:  Pharmacol Biochem Behav       Date:  2011-02-24       Impact factor: 3.533

5.  Differential effects of non-nicotine tobacco constituent compounds on nicotine self-administration in rats.

Authors:  Brandon J Hall; Corinne Wells; Cheyenne Allenby; Mung Yan Lin; Ian Hao; Lindsey Marshall; Jed E Rose; Edward D Levin
Journal:  Pharmacol Biochem Behav       Date:  2014-02-21       Impact factor: 3.533

Review 6.  Striatal alpha6* nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapy.

Authors:  Maryka Quik; J Michael McIntosh
Journal:  J Pharmacol Exp Ther       Date:  2005-10-06       Impact factor: 4.030

7.  Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory.

Authors:  E D Levin; A Bradley; N Addy; N Sigurani
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

Review 8.  The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).

Authors:  W R Kem
Journal:  Behav Brain Res       Date:  2000-08       Impact factor: 3.332

9.  Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats.

Authors:  R Felix; E D Levin
Journal:  Neuroscience       Date:  1997-12       Impact factor: 3.590

10.  Cholinergic modulation of locomotion and striatal dopamine release is mediated by alpha6alpha4* nicotinic acetylcholine receptors.

Authors:  Ryan M Drenan; Sharon R Grady; Andrew D Steele; Sheri McKinney; Natalie E Patzlaff; J Michael McIntosh; Michael J Marks; Julie M Miwa; Henry A Lester
Journal:  J Neurosci       Date:  2010-07-21       Impact factor: 6.167

View more
  12 in total

1.  Cognitive and Behavioral Impairments Evoked by Low-Level Exposure to Tobacco Smoke Components: Comparison with Nicotine Alone.

Authors:  Brandon J Hall; Marty Cauley; Dennis A Burke; Abtin Kiany; Theodore A Slotkin; Edward D Levin
Journal:  Toxicol Sci       Date:  2016-02-26       Impact factor: 4.849

2.  Nicotine mediates expression of genes related to antioxidant capacity and oxidative stress response in HIV-1 transgenic rat brain.

Authors:  Guohua Song; Tanseli Nesil; Junran Cao; Zhongli Yang; Sulie L Chang; Ming D Li
Journal:  J Neurovirol       Date:  2015-08-26       Impact factor: 2.643

3.  Differential effects of alkaloids on memory in rodents.

Authors:  Patrick M Callahan; Alvin V Terry; Manuel C Peitsch; Julia Hoeng; Kyoko Koshibu
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

4.  Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD.

Authors:  Megha Verma; David Beaulieu-Abdelahad; Ghania Ait-Ghezala; Rena Li; Fiona Crawford; Michael Mullan; Daniel Paris
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

5.  Cadmium increases the sensitivity of adolescent female mice to nicotine-related behavioral deficits.

Authors:  Philip Adeyemi Adeniyi; Babawale Peter Olatunji; Azeez Olakunle Ishola; Duyilemi Chris Ajonijebu; Olalekan Michael Ogundele
Journal:  Behav Neurol       Date:  2014-11-16       Impact factor: 3.342

6.  A Pharmacological Comparison of Two Isomeric Nicotinic Receptor Agonists: The Marine Toxin Isoanatabine and the Tobacco Alkaloid Anatabine.

Authors:  Hong Xing; Sunil Keshwah; Anne Rouchaud; William R Kem
Journal:  Mar Drugs       Date:  2020-02-11       Impact factor: 5.118

7.  A 3-month-delayed treatment with anatabine improves chronic outcomes in two different models of repetitive mild traumatic brain injury in hTau mice.

Authors:  Alexander Morin; Benoit Mouzon; Scott Ferguson; Daniel Paris; Nicole Saltiel; Mackenzie Browning; Mike Mullan; Fiona Crawford
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

8.  Vortioxetine Differentially Modulates MK-801-Induced Changes in Visual Signal Detection Task Performance and Locomotor Activity.

Authors:  Todd M Hillhouse; Christina R Merritt; Douglas A Smith; Manuel Cajina; Connie Sanchez; Joseph H Porter; Alan L Pehrson
Journal:  Front Pharmacol       Date:  2018-09-13       Impact factor: 5.810

Review 9.  Pyridine alkaloids with activity in the central nervous system.

Authors:  Simon X Lin; Maurice A Curtis; Jonathan Sperry
Journal:  Bioorg Med Chem       Date:  2020-10-16       Impact factor: 3.641

10.  Effects of nicotinic acetylcholine receptor-activating alkaloids on anxiety-like behavior in zebrafish.

Authors:  Ainhoa Alzualde; Oihane Jaka; Diogo A R S Latino; Omar Alijevic; Iñaki Iturria; Jorge Hurtado de Mendoza; Pavel Pospisil; Stefan Frentzel; Manuel C Peitsch; Julia Hoeng; Kyoko Koshibu
Journal:  J Nat Med       Date:  2021-07-15       Impact factor: 2.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.